These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18815725)

  • 41. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
    Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
    Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
    Albers HM; Wessels JA; van der Straaten RJ; Brinkman DM; Suijlekom-Smit LW; Kamphuis SS; Girschick HJ; Wouters C; Schilham MW; le Cessie S; Huizinga TW; Ten Cate R; Guchelaar HJ
    Arthritis Rheum; 2009 Jan; 61(1):46-51. PubMed ID: 19116975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.
    Chang CY; Meyer RM; Reiff AO
    Arthritis Care Res (Hoboken); 2015 May; 67(5):658-66. PubMed ID: 25220674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ; LIVER LESION IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS WITH DIFFERENT DURATION OF METHOTREXATE TREATMENT.
    Panko N; Tsiura O; Shevchenko N; Zimnytska T
    Georgian Med News; 2020; (304-305):95-99. PubMed ID: 32965257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methotrexate in the treatment of juvenile rheumatoid arthritis and other pediatric rheumatoid and nonrheumatic disorders.
    Singsen BH; Goldbach-Mansky R
    Rheum Dis Clin North Am; 1997 Nov; 23(4):811-40. PubMed ID: 9361157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry.
    Foeldvari I; Becker I; Horneff G
    Arthritis Care Res (Hoboken); 2015 Nov; 67(11):1529-35. PubMed ID: 25988824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Recommendations for the use of methotrexate in patients with juvenile idiopathic arthritis].
    Calvo I; Antón J; López Robledillo JC; de Inocencio J; Gamir ML; Merino R; Lacruz L; Camacho M; Rua MJ; Bustabad S; Díaz Cordovés-Rego G
    An Pediatr (Barc); 2016 Mar; 84(3):177.e1-8. PubMed ID: 26077957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclosporine A in juvenile idiopathic arthritis. Results of the PRCSG/PRINTO phase IV post marketing surveillance study.
    Ruperto N; Ravelli A; Castell E; Gerloni V; Haefner R; Malattia C; Kanakoudi-Tsakalidou F; Nielsen S; Bohnsack J; Gibbas D; Rennebohm R; Voygioyka O; Balogh Z; Lepore L; Macejkova E; Wulffraat N; Oliveira S; Russo R; Buoncompagni A; Hilário MO; Alpigiani MG; Passo M; Lovell DJ; Merino R; Martini A; Giannini EH; ;
    Clin Exp Rheumatol; 2006; 24(5):599-605. PubMed ID: 17181934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical treatment of juvenile idiopathic arthritis.
    Hashkes PJ; Laxer RM
    JAMA; 2005 Oct; 294(13):1671-84. PubMed ID: 16204667
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook.
    Selvestrel D; Lucafò M; Pugnetti L; Pagarin S; Moressa V; Pastore S; Taddio A; Stocco G; Decorti G
    Expert Rev Clin Immunol; 2021 Oct; 17(10):1131-1142. PubMed ID: 34392756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The experience of taking methotrexate for juvenile idiopathic arthritis: results of a cross-sectional survey with children and young people.
    Mulligan K; Wedderburn LR; Newman S
    Pediatr Rheumatol Online J; 2015 Dec; 13():58. PubMed ID: 26653415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate.
    Moncrieffe H; Bennett MF; Tsoras M; Luyrink LK; Johnson AL; Xu H; Dare J; Becker ML; Prahalad S; Rosenkranz M; O'Neil KM; Nigrovic PA; Griffin TA; Lovell DJ; Grom AA; Medvedovic M; Thompson SD
    Rheumatology (Oxford); 2017 Sep; 56(9):1542-1551. PubMed ID: 28582527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.
    Tynjälä P; Vähäsalo P; Tarkiainen M; Kröger L; Aalto K; Malin M; Putto-Laurila A; Honkanen V; Lahdenne P
    Ann Rheum Dis; 2011 Sep; 70(9):1605-12. PubMed ID: 21623000
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High doses of infliximab in the management of juvenile idiopathic arthritis.
    Tambralli A; Beukelman T; Weiser P; Atkinson TP; Cron RQ; Stoll ML
    J Rheumatol; 2013 Oct; 40(10):1749-55. PubMed ID: 23950184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
    Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A;
    Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept.
    Borte S; Liebert UG; Borte M; Sack U
    Rheumatology (Oxford); 2009 Feb; 48(2):144-8. PubMed ID: 19074187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis.
    Bulatovic M; Heijstek MW; Van Dijkhuizen EH; Wulffraat NM; Pluijm SM; de Jonge R
    Ann Rheum Dis; 2012 Sep; 71(9):1484-9. PubMed ID: 22473625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proposal for juvenile idiopathic arthritis guidance on diagnosis and treatment for primary care pediatricians and nonpediatric rheumatologists (2007).
    Yokota S; Mori M; Imagawa T; Takei S; Murata T; Tomiita M; Ito Y; Fujikawa S
    Mod Rheumatol; 2007; 17(5):353-63. PubMed ID: 17929125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics.
    Barthel D; Ganser G; Kuester RM; Onken N; Minden K; Girschick HJ; Hospach A; Horneff G
    J Rheumatol; 2015 Nov; 42(11):2160-5. PubMed ID: 26373564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-adalimumab antibodies in juvenile idiopathic arthritis: frequent association with loss of response.
    Skrabl-Baumgartner A; Erwa W; Muntean W; Jahnel J
    Scand J Rheumatol; 2015; 44(5):359-62. PubMed ID: 25974288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.